BMG LABTECH announces integration of entire product range with Genedata Screener

One single analysis platform to streamline workflows, reduce costs, and lower maintenance efforts

BMG LABTECH collaborates with Genedata to provide a functionally rich integration between BMG LABTCH’s entire product range of dedicated and multi-mode microplate readers and Genedata Screener®, a data analysis and management platform for in-vitro screening technologies.

By focussing on the needs of the scientific community, we constantly strive toenhance the usability of our products and to optimise workflows beyond our microplate readers through collaborations with other companies. The Genedata Ready-to-Run integration enables customers to easily import the high-quality results of our readers into a platform that takes data analysis and management in screening facilities to a new level"

Thomas Räbiger, CEO at BMG LABTECH.

BMG LABTECH’s multi-mode microplate readers PHERAstar® FSX,CLARIOstar® and Omega Series as well as the dedicated SPECTROstar® Nanoare part of the Genedata Ready-to-Run program.

The readers offer solutions for any screening assay and are used by leading pharmaceutical companies and academic research institutions all over the world. The microplate readers have earned the reputation of highest sensitivity, speed and precision for life science applications and high-throughput screening purposes.

A perfectly engineered instrument is only one part of the solution. It needs to be effectively integrated in modern screening laboratories to visualize, analyse and manage data in the same workflow,”

Andrea Krumm, Application Scientist at BMG LABTECH.

The company’s microplate readers come with a powerful software package including control software and the MARS data analysis software, which effectively run the microplate reader and extensively analyze data.

“The GenedataScreener® Ready-to-Run program enhances our capabilities as it provides out-of-the-box integrations for complex screening technologies making it the perfect addition to all of our readers, but especially the PHERAstar® FSX, the gold standard microplate reader for high-throughput screening,” explains Krumm.

Designed to import data from any screening instrument, GenedataScreener® can handle a range of data from small data sets to extensive experiments with thousands of plates as in ultra-high throughput trials.

“The integration with Genedata Screener® helps our customers to reduce data analysis time and minimize efforts by decreasing manual errors and interpretation mistakes. The platform further helps customers to gain a deeper understanding of complex experiments and encourages scientific collaboration through secure data sharing,” says Krumm.

The cooperation will be announced at SLAS 2017 in Washington DC, where BMG LABTECH (booth 529) and Genedata (booth 541) offer detailed information about the Ready-to-Run program.

The integration will be available from early spring 2017 and requires little to no configuration for BMG LABTECH customers. It is instrument-specific, comes with defined functionality, and is maintained by Genedata as part of a software license agreement.


Please use one of the following formats to cite this article in your essay, paper or report:

  • APA

    BMG LABTECH GmbH. (2023, March 22). BMG LABTECH announces integration of entire product range with Genedata Screener. News-Medical. Retrieved on May 27, 2024 from

  • MLA

    BMG LABTECH GmbH. "BMG LABTECH announces integration of entire product range with Genedata Screener". News-Medical. 27 May 2024. <>.

  • Chicago

    BMG LABTECH GmbH. "BMG LABTECH announces integration of entire product range with Genedata Screener". News-Medical. (accessed May 27, 2024).

  • Harvard

    BMG LABTECH GmbH. 2023. BMG LABTECH announces integration of entire product range with Genedata Screener. News-Medical, viewed 27 May 2024,


The opinions expressed here are the views of the writer and do not necessarily reflect the views and opinions of News Medical.
Post a new comment

While we only use edited and approved content for Azthena answers, it may on occasions provide incorrect responses. Please confirm any data provided with the related suppliers or authors. We do not provide medical advice, if you search for medical information you must always consult a medical professional before acting on any information provided.

Your questions, but not your email details will be shared with OpenAI and retained for 30 days in accordance with their privacy principles.

Please do not ask questions that use sensitive or confidential information.

Read the full Terms & Conditions.

You might also like...
CLARIOstar used for fluorescence measurements on CSIRO's purpose-built research vessel